Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan Apter

Showing results (11-20 of 86) with videos related to

Pageof 9
Sort By:
Endocrine Development|August 1, 2012
Sexuality education: Finnish and Chilean experiencesDan Apter, Ramiro Molina Cartes
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|May 9, 2007
Preventing common sexually transmitted infections in adolescents: time for rethinkingMatti Lehtinen, Jorma Paavonen, Dan Apter
Duodecim; Laaketieteellinen Aikakauskirja|August 15, 2009
[HPV and effectiveness of chlamydia control]Matti Lehtinen, Tiina Eriksson, Dan Apter
Fertility and Sterility|January 7, 2012
A randomized, phase II study describing the efficacy, bleeding profile, and safety of two low-dose levonorgestrel-releasing intrauterine contraceptive systems and MirenaKristina Gemzell-Danielsson, Ilka Schellschmidt, Dan Apter
Women'S Health (London, England)|September 27, 2014
Prevention of HPV disease burdenMatti Lehtinen, Pekka Nieminen, Dan Apter, et al.
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|July 16, 2013
Conscientious objection and induced abortion in EuropeAnna Heino, Mika Gissler, Dan Apter, et al.
Contraception|February 24, 2020
Multicenter, open-label trial to assess the safety and tolerability of drospirenone 4.0 mg over 6 cycles in female adolescents, with a 7-cycle extension phaseDan Apter, Enrico Colli, Kristina Gemzell-Danielsson, et al.
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|February 8, 2018
The risk of cervical atypia in oral contraceptive usersIndira Adhikari, Tiina Eriksson, Tapio Luostarinen, et al.
BMJ Open|September 13, 2019
Is the risk of cervical atypia associated with the interval between menarche and the start of sexual activity? A population-based cohort studyIndira Adhikari, Tiina Eriksson, Tapio Luostarinen, et al.
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|October 6, 2016
Targeting factors for change: contraceptive counselling and care of female adolescentsJohannes Bitzer, Virginia Abalos, Dan Apter, et al.
Pageof 9

Showing results (11-20 of 86) with videos related to

Sort By:
Pageof 9
Endocrine Development|August 1, 2012
Sexuality education: Finnish and Chilean experiencesDan Apter, Ramiro Molina Cartes
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|May 9, 2007
Preventing common sexually transmitted infections in adolescents: time for rethinkingMatti Lehtinen, Jorma Paavonen, Dan Apter
Duodecim; Laaketieteellinen Aikakauskirja|August 15, 2009
[HPV and effectiveness of chlamydia control]Matti Lehtinen, Tiina Eriksson, Dan Apter
Fertility and Sterility|January 7, 2012
A randomized, phase II study describing the efficacy, bleeding profile, and safety of two low-dose levonorgestrel-releasing intrauterine contraceptive systems and MirenaKristina Gemzell-Danielsson, Ilka Schellschmidt, Dan Apter
Women'S Health (London, England)|September 27, 2014
Prevention of HPV disease burdenMatti Lehtinen, Pekka Nieminen, Dan Apter, et al.
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|July 16, 2013
Conscientious objection and induced abortion in EuropeAnna Heino, Mika Gissler, Dan Apter, et al.
Contraception|February 24, 2020
Multicenter, open-label trial to assess the safety and tolerability of drospirenone 4.0 mg over 6 cycles in female adolescents, with a 7-cycle extension phaseDan Apter, Enrico Colli, Kristina Gemzell-Danielsson, et al.
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|February 8, 2018
The risk of cervical atypia in oral contraceptive usersIndira Adhikari, Tiina Eriksson, Tapio Luostarinen, et al.
BMJ Open|September 13, 2019
Is the risk of cervical atypia associated with the interval between menarche and the start of sexual activity? A population-based cohort studyIndira Adhikari, Tiina Eriksson, Tapio Luostarinen, et al.
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|October 6, 2016
Targeting factors for change: contraceptive counselling and care of female adolescentsJohannes Bitzer, Virginia Abalos, Dan Apter, et al.
Pageof 9